Macular Disease Foundation Australia logo

    AMD: Classification, AREDS studies and management

    This CPD webinar on management of age-related macular degeneration will focus on clinical implications for optometrists.

    Alex Hunyor on blue background

    This webinar will examine the classification of AMD, results and relevance of the AREDS studies, and current referral guidelines and their implications for clinical practice. Case studies will be included to consolidate learning. Attendees will have an opportunity to guide discussion by pre submitting questions on registration.

    This webinar is aimed at optometrists. It will be presented by Associate Professor Alex Hunyor, who is the Chair of the Medical Committee of Macular Disease Foundation Australia, and an MDFA Board member.

    When: Wednesday 29 September

    Time: 6:30-7:30pm AEST

    Where: online

    Learning objectives

    Upon completion of this CPD activity participants will be confident to classify AMD using the Beckman classification, recognise the clinical implications of the AREDS studies, and prioritise referrals based on current guidelines.


    Optometry Australia Quality Assured 1 hour of learning.

    About the presenter

    Associate Professor Alex Hunyor (MB BS (Hons), FRANZCO) is a retinal specialist with expertise in vitreoretinal surgery and macular disease. 

    He graduated with Honours from Sydney University Medical School in 1990, and trained in ophthalmology at the Royal Victorian Eye and Ear Hospital (RVEEH) in Melbourne. He was awarded both the Cedric Cohen and the Ken Howsam Medals for excellence in the RANZCO examinations, and the RANZCO-ARVO and RANZCO-Sigma Scholarships.

    He then undertook three and a half years of subspecialty training in medical and surgical retina at RVEEH, the Casey Eye Institute (Portland, Oregon USA) and with Professor JDM Gass at Vanderbilt University (Nashville, TN).

    Alex is a Clinical Associate Professor and member of the Macular Research Group at the Save Sight Institute, University of Sydney. He is involved in numerous clinical trials for treatment of retinal diseases. He’s a member of the Australian and New Zealand Society of Retinal Specialists, Oceania Retina Association, American Academy of Ophthalmology, Association for Research in Vision and Ophthalmology, and the American Society of Retina Specialists (ASRS). He is the Australian international delegate to the ASRS.

    Alex is the Chair of the Medical Committee of Macular Disease Foundation Australia, and an MDFA Board member. Alex serves on the RANZCO Medicare Advisory Committee, and is involved in teaching of optometrists, ophthalmic trainees and local and international ophthalmologists. He also participates in education of overseas specialists through the RANZCO International Development Programme and Sight For All. Alex has received the RANZCO Award for Excellence in Training four times. 

    He has given many lectures at local and international scientific meetings, has over 60 peer-reviewed journal publications, and serves as a reviewer for numerous ophthalmic journals as well as the Medical Journal of Australia.